Avoro Capital Advisors LLC Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$7508.4T
Holdings
41
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (41 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | UTHUNITED THERAPEUTICS CORP | 2,858,888 | $910.7T | 12.13% | |
| 2 | MDGLMADRIGAL PHARMACEUTICALS INC | 2,055,555 | $575.9T | 7.67% | |
| 3 | ASNDASCENDIS PHARMA | 4,196,661 | $572.3T | 7.62% | |
| 4 | ARGXARGENX SE | 1,238,467 | $532.6T | 7.09% | |
| 5 | SRPTSAREPTA THERAPEUTICS INC | 3,000,000 | $474.0T | 6.31% | |
| 6 | KRYSKRYSTAL BIOTECH INC | 2,433,000 | $446.8T | 5.95% | |
| 7 | APLSAPELLIS PHARMACEUTICALS INC. | 11,111,111 | $426.2T | 5.68% | |
| 8 | BMRNBIOMARIN PHARMACEUTICAL INC | 4,557,416 | $375.2T | 5.00% | |
| 9 | CERE1EURCEREVEL THERAPEUTICS HLDNG | 7,539,547 | $308.3T | 4.11% | |
| 10 | XBISPDR SERIES TRUST - S&P BIOTECH | 3,035,000 | $281.4T | 3.75% | |
| 11 | AM6AMICUS THERAPEUTICS INC. | 27,400,000 | $271.8T | 3.62% | |
| 12 | RNAAVIDITY BIOSCIENCES INC | 6,505,000 | $265.7T | 3.54% | |
| 13 | ARWRARROWHEAD PHARMACEUTICALS INC. | 8,888,888 | $231.0T | 3.08% | |
| 14 | XENEXENON PHARMACEUTICALS INC | 5,666,666 | $220.9T | 2.94% | |
| 15 | ITCIEURINTRA-CELLULAR THERAPIES INC | 3,000,000 | $205.5T | 2.74% | |
| 16 | VERAVERA THERAPEUTICS INC | 4,309,590 | $155.9T | 2.08% | |
| 17 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 2,770,000 | $121.8T | 1.62% | |
| 18 | KYMRKYMERA THERAPEUTICS INC | 3,888,888 | $116.1T | 1.55% | |
| 19 | ALNYALNYLAM PHARMCEUTICALS INC. | 400,000 | $97.2T | 1.29% | |
| 20 | IOVAIOVANCE BIOTHERAPEUTICS INC | 11,700,000 | $93.8T | 1.25% | |
| 21 | SLNOSOLENO THERAPEUTICS INC | 2,091,666 | $85.3T | 1.14% | |
| 22 | MRUSMERUS N V | 1,355,000 | $80.2T | 1.07% | |
| 23 | SNDXSYNDAX PHARMACEUTICALS INC | 3,888,437 | $79.8T | 1.06% | |
| 24 | BCRXBIOCRYST PHARMACEUTICALS INC | 12,570,000 | $77.7T | 1.03% | |
| 25 | KURAKURA ONCOLOGY INC | 3,541,505 | $72.9T | 0.97% | |
| 26 | OCULOCULAR THERAPEUTIX INC | 8,060,000 | $55.1T | 0.73% | |
| 27 | MNKDMANNKIND CORP | 8,759,524 | $45.7T | 0.61% | |
| 28 | PCVXVAXCYTE INC | 575,000 | $43.4T | 0.58% | |
| 29 | SYRESPYRE THERAPEUTICS INC | 1,839,138 | $43.2T | 0.58% | |
| 30 | AUTLAUTOLUS THERAPEUTICS PLC | 12,345,678 | $43.0T | 0.57% | |
| 31 | TSHATAYSHA GENE THERAPIES INC | 18,650,000 | $41.8T | 0.56% | |
| 32 | RAREULTRAGENYX PHARMACEUTICAL INC | 830,000 | $34.1T | 0.45% | |
| 33 | VRCAVERRICA PHARMACEUTICALS INC | 3,999,999 | $29.2T | 0.39% | |
| 34 | TRMLTOURMALINE BIO INC | 2,222,222 | $28.6T | 0.38% | |
| 35 | CGONCG ONCOLOGY INC | 700,000 | $22.1T | 0.29% | |
| 36 | GLUEMONTE ROSA THERAPEUTICS INC | 4,535,000 | $17.0T | 0.23% | |
| 37 | BCYCBICYCLE THERAPEUTICS PLC | 700,000 | $14.2T | 0.19% | |
| 38 | WHWKAADI BIOSCIENCES INC | 2,849,402 | $4.2T | 0.06% | |
| 39 | DYNDYNE THERAPEUTICS INC. | 115,751 | $4.1T | 0.05% | |
| 40 | AVU0ADVERUM BIOTECHNOLOGIES INC | 416,666 | $2.9T | 0.04% | |
| 41 | NGNENEUROGENE INC | 22,029 | $801.6B | 0.01% |